Thrivelab Review

What Thrivelab charges

• Semaglutide: $175/mo — intro month; following months are stated as a range, "$175-250 … Based on provider recommendation dosage"
• Semaglutide: $225/mo — intro month; following months are stated only as "$300+"

Thrivelab also sells 8 compounds this site boards without publishing a price for them: NAD+, BPC-157 (board ranks no provider), TB-500 (board ranks no provider), KPV (board ranks no provider), Sermorelin, Ipamorelin (board ranks no provider), Tesamorelin and MOTS-C (board ranks no provider).

Its peptide page names compounds and prices none of them

The peptide page lists ten compounds this site tracks and attaches a figure to not one of them.

The only prices published anywhere are on the weight-loss page, for its injectable and oral semaglutide.

So a reader arriving to compare a peptide leaves with nothing to compare.

The grey-market warning is aimed outward, not at itself

It writes: "Many peptides sold online are labeled 'research peptides' and are not intended for human use. These products are often sold without medical oversight."

That is a seller warning readers about the grey market, not a seller describing its own goods, and it reads differently from the research-use hedging that some vendors put on their own products.

Its own sourcing sentence is the opposite of that: "All peptides at Thrivelab are sourced from licensed, 503A compounding pharmacies."

Its biggest number belongs to somebody else

A comparison table headed "Other providers vs. thrivelab" carries a wide monthly range in the column for other semaglutide providers, under a heading about hidden platform fees.

That figure is a competitor column, not this seller's price, and nothing is filed from it here.

It is the same trap that has caught other sellers on this roster, where the largest number on a page is one the seller is arguing against.

What the published prices actually say

Both weight-loss figures are intro-month rates, and the site says so.

For the injectable, following months are given as a range based on the provider's recommended dosage; for the oral, following months are given only as an open-ended floor.

So the standing price after the first month is not a number on either product, and it is stated in the seller's own words that it varies.

How we verified this

• Read the peptide page in full and confirmed it attaches no figure to any of the ten tracked compounds it names.
• Read the largest number on the site in its own column heading, confirmed it describes other providers, and filed nothing from it.
• Recorded both weight-loss figures as intro-month rates with the seller's own words about what follows, rather than treating either as a standing price.
• Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
• Screened the brand against the live federal warning-letter table, pulling all 3,677 records in pages and filtering locally because the table's own search parameter is ignored, with a positive and a nonsense control in the same run. No letters.